Last reviewed · How we verify

Lumefantrine-artemether and nevirapine

Makerere University · FDA-approved active Small molecule Quality 0/100

Lumefantrine-artemether and nevirapine is a Small molecule drug developed by Makerere University. It is currently FDA-approved. Also known as: Coartem, Triomune.

Lumefantrine-artemether and nevirapine, marketed by Makerere University, is a combination therapy currently available in the market. The key composition patent expires in 2028, providing a period of exclusivity that supports its competitive position. The primary risk is the lack of reported revenue and key trial results, which may limit investor confidence and market adoption.

At a glance

Generic nameLumefantrine-artemether and nevirapine
Also known asCoartem, Triomune
SponsorMakerere University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Lumefantrine-artemether and nevirapine

What is Lumefantrine-artemether and nevirapine?

Lumefantrine-artemether and nevirapine is a Small molecule drug developed by Makerere University.

Who makes Lumefantrine-artemether and nevirapine?

Lumefantrine-artemether and nevirapine is developed and marketed by Makerere University (see full Makerere University pipeline at /company/makerere-university).

Is Lumefantrine-artemether and nevirapine also known as anything else?

Lumefantrine-artemether and nevirapine is also known as Coartem, Triomune.

What development phase is Lumefantrine-artemether and nevirapine in?

Lumefantrine-artemether and nevirapine is FDA-approved (marketed).

Related